Matches in Wikidata for { <http://www.wikidata.org/entity/Q58643208> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q58643208 description "article scientifique (publié 2006)" @default.
- Q58643208 description "artikull shkencor i botuar më 01 janar 2006" @default.
- Q58643208 description "artículu científicu espublizáu en xineru de 2006" @default.
- Q58643208 description "im Jahr 2006 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58643208 description "scientific article published on 01 January 2006" @default.
- Q58643208 description "wetenschappelijk artikel" @default.
- Q58643208 description "наукова стаття, опублікована в січні 2006" @default.
- Q58643208 name "Treatment With Infliximab Is Associated With Increased Markers of Bone Formation in Patients With Crohn??s Disease" @default.
- Q58643208 name "Treatment With Infliximab Is Associated With Increased Markers of Bone Formation in Patients With Crohn??s Disease" @default.
- Q58643208 name "Treatment With Infliximab Is Associated With Increased Markers of Bone Formation in Patients With Crohn??s Disease" @default.
- Q58643208 type Item @default.
- Q58643208 label "Treatment With Infliximab Is Associated With Increased Markers of Bone Formation in Patients With Crohn??s Disease" @default.
- Q58643208 label "Treatment With Infliximab Is Associated With Increased Markers of Bone Formation in Patients With Crohn??s Disease" @default.
- Q58643208 label "Treatment With Infliximab Is Associated With Increased Markers of Bone Formation in Patients With Crohn??s Disease" @default.
- Q58643208 prefLabel "Treatment With Infliximab Is Associated With Increased Markers of Bone Formation in Patients With Crohn??s Disease" @default.
- Q58643208 prefLabel "Treatment With Infliximab Is Associated With Increased Markers of Bone Formation in Patients With Crohn??s Disease" @default.
- Q58643208 prefLabel "Treatment With Infliximab Is Associated With Increased Markers of Bone Formation in Patients With Crohn??s Disease" @default.
- Q58643208 P1433 Q58643208-5796E295-3D30-4227-948B-30BF84B1C833 @default.
- Q58643208 P1476 Q58643208-B08A75F9-03F6-46C6-9C75-ABD3DAEAFC5A @default.
- Q58643208 P2093 Q58643208-04FE1CAD-A3F4-4474-8753-B5968424DD54 @default.
- Q58643208 P2093 Q58643208-2277ABAA-9BB8-4727-AD8A-125C19208398 @default.
- Q58643208 P2093 Q58643208-3112F839-BFEA-4BAD-8AF6-1A54E4A6B65B @default.
- Q58643208 P2093 Q58643208-5413F7B6-59DD-4551-B104-5B53097FE7EC @default.
- Q58643208 P2093 Q58643208-61925B76-A0CC-46F4-99AB-5AF2F433E73F @default.
- Q58643208 P2093 Q58643208-9F186934-D2DB-4087-B859-2C7502399BF3 @default.
- Q58643208 P2093 Q58643208-B39A84AA-E4BC-4422-A842-224CB7BB5953 @default.
- Q58643208 P2093 Q58643208-C8BDAF0C-FA09-4887-99C1-EF8827C7C8B4 @default.
- Q58643208 P2093 Q58643208-DD31E661-07CE-4B04-AAB7-2376B7FC10EE @default.
- Q58643208 P2093 Q58643208-EE16FB01-8F2B-4EBE-8B58-AF0B31E758A6 @default.
- Q58643208 P304 Q58643208-0CAF64FF-34CA-454F-9069-DADDA12B03B4 @default.
- Q58643208 P31 Q58643208-131982D0-3E85-4004-8999-742B66BD89E3 @default.
- Q58643208 P356 Q58643208-624FC293-0CC1-4333-BBE9-980F18835B7D @default.
- Q58643208 P433 Q58643208-61745D01-15D6-4217-8C0A-18EEAB0538EC @default.
- Q58643208 P478 Q58643208-BC8222D2-DD8A-44A0-A060-B493809075F5 @default.
- Q58643208 P50 Q58643208-484CF302-FB25-4933-ABA0-111DDC60540F @default.
- Q58643208 P50 Q58643208-5F7086D0-F64B-43E5-AD5F-19111EF4DC91 @default.
- Q58643208 P50 Q58643208-AD1DD3FA-EE02-49E6-B3B8-86177221C7A3 @default.
- Q58643208 P50 Q58643208-DD0A83C9-A47E-46C4-86A4-B7506E2DB3A1 @default.
- Q58643208 P577 Q58643208-8ADD98BF-0FFB-4A23-BA04-6E943AC960E0 @default.
- Q58643208 P698 Q58643208-0318E6C6-4857-4DAD-AA9E-0ECF814C8143 @default.
- Q58643208 P356 01.MCG.0000190762.80615.D4 @default.
- Q58643208 P698 16340635 @default.
- Q58643208 P1433 Q15710046 @default.
- Q58643208 P1476 "Treatment with infliximab is associated with increased markers of bone formation in patients with Crohn's disease" @default.
- Q58643208 P2093 "Carol J Landers" @default.
- Q58643208 P2093 "Eric A Vasiliauskas" @default.
- Q58643208 P2093 "Gregory Keenan" @default.
- Q58643208 P2093 "Huiying Yang" @default.
- Q58643208 P2093 "Joanne Price" @default.
- Q58643208 P2093 "Jordan L Geller" @default.
- Q58643208 P2093 "Lenna A Martyak" @default.
- Q58643208 P2093 "Lori Y Kam" @default.
- Q58643208 P2093 "Puja Vora" @default.
- Q58643208 P2093 "Ying-Chao Lin" @default.
- Q58643208 P304 "55-63" @default.
- Q58643208 P31 Q13442814 @default.
- Q58643208 P356 "10.1097/01.MCG.0000190762.80615.D4" @default.
- Q58643208 P433 "1" @default.
- Q58643208 P478 "40" @default.
- Q58643208 P50 Q106967049 @default.
- Q58643208 P50 Q41591669 @default.
- Q58643208 P50 Q77810607 @default.
- Q58643208 P50 Q81600125 @default.
- Q58643208 P577 "2006-01-01T00:00:00Z" @default.
- Q58643208 P698 "16340635" @default.